- Home
- GITS vs BJDX Comparison
GITS vs BJDX Comparison
Compare GITS & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GITS | BJDX |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8M | 2.6M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | GITS | BJDX |
|---|---|---|
| Price | $2.75 | $3.05 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 7.7M | 132.5K |
| Earning Date | 11-12-2025 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,867.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $55.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.66 | $2.51 |
| 52 Week High | $7.09 | $40.80 |
Technical Indicators
Market Signals| Indicator | GITS | BJDX |
|---|---|---|
| Relative Strength Index (RSI) | 53.33 | 65.80 |
| Support Level | $2.62 | $2.84 |
| Resistance Level | $4.65 | $3.60 |
| Average True Range (ATR) | 1.09 | 0.42 |
| MACD | -0.10 | 0.10 |
| Stochastic Oscillator | 16.16 | 73.89 |
Price Performance
Historical ComparisonAbout GITS Global Interactive Technologies Inc.
Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.
About BJDX Bluejay Diagnostics Inc.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from 'sample-to-result' to help medical professionals make earlier and better triage/treatment decisions.